87 related articles for article (PubMed ID: 20467815)
1. Kinetics of ERK1/2 activation determine sensitivity of acute myeloid leukaemia cells to the induction of apoptosis by the novel small molecule ingenol 3-angelate (PEP005).
Hampson P; Wang K; Milverton L; Ersvaer E; Bruserud O; Lord JM
Apoptosis; 2010 Aug; 15(8):946-55. PubMed ID: 20467815
[TBL] [Abstract][Full Text] [Related]
2. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells.
Serova M; Ghoul A; Benhadji KA; Faivre S; Le Tourneau C; Cvitkovic E; Lokiec F; Lord J; Ogbourne SM; Calvo F; Raymond E
Mol Cancer Ther; 2008 Apr; 7(4):915-22. PubMed ID: 18413805
[TBL] [Abstract][Full Text] [Related]
3. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC.
Hampson P; Chahal H; Khanim F; Hayden R; Mulder A; Assi LK; Bunce CM; Lord JM
Blood; 2005 Aug; 106(4):1362-8. PubMed ID: 15845901
[TBL] [Abstract][Full Text] [Related]
4. Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta.
Lee WY; Hampson P; Coulthard L; Ali F; Salmon M; Lord JM; Scheel-Toellner D
J Biol Chem; 2010 Jul; 285(31):23889-98. PubMed ID: 20472553
[TBL] [Abstract][Full Text] [Related]
5. Activation of PKCdelta and ERK1/2 in the sensitivity to UV-induced apoptosis of human cells harboring 4977 bp deletion of mitochondrial DNA.
Liu CY; Lee CF; Wei YH
Biochim Biophys Acta; 2009 Aug; 1792(8):783-90. PubMed ID: 19477272
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner.
Hampson P; Kavanagh D; Smith E; Wang K; Lord JM; Ed Rainger G
Cancer Immunol Immunother; 2008 Aug; 57(8):1241-51. PubMed ID: 18265980
[TBL] [Abstract][Full Text] [Related]
7. The protein kinase C agonist PEP005 increases NF-kappaB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells.
Olsnes AM; Ersvaer E; Ryningen A; Paulsen K; Hampson P; Lord JM; Gjertsen BT; Kristoffersen EK; Bruserud Ø
Br J Haematol; 2009 Jun; 145(6):761-74. PubMed ID: 19388934
[TBL] [Abstract][Full Text] [Related]
8. Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C.
Mhaidat NM; Thorne RF; Zhang XD; Hersey P
Mol Cancer Res; 2007 Oct; 5(10):1073-81. PubMed ID: 17951407
[TBL] [Abstract][Full Text] [Related]
9. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP.
Sumarni U; Reidel U; Eberle J
Cells; 2021 Apr; 10(5):. PubMed ID: 33922439
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}.
Mertens-Walker I; Bolitho C; Baxter RC; Marsh DJ
Endocr Relat Cancer; 2010 Jun; 17(2):335-49. PubMed ID: 20215102
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells.
Benhadji KA; Serova M; Ghoul A; Cvitkovic E; Le Tourneau C; Ogbourne SM; Lokiec F; Calvo F; Hammel P; Faivre S; Raymond E
Br J Cancer; 2008 Dec; 99(11):1808-15. PubMed ID: 19034280
[TBL] [Abstract][Full Text] [Related]
13. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
Edwards SK; Moore CR; Liu Y; Grewal S; Covey LR; Xie P
BMC Cancer; 2013 Oct; 13():481. PubMed ID: 24131623
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
15. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.
Wu J; Wong WW; Khosravi F; Minden MD; Penn LZ
Cancer Res; 2004 Sep; 64(18):6461-8. PubMed ID: 15374955
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of protein kinase Cdelta on distinct tyrosine residues induces sustained activation of Erk1/2 via down-regulation of MKP-1: role in the apoptotic effect of etoposide.
Lomonaco SL; Kahana S; Blass M; Brody Y; Okhrimenko H; Xiang C; Finniss S; Blumberg PM; Lee HK; Brodie C
J Biol Chem; 2008 Jun; 283(25):17731-9. PubMed ID: 18434324
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation.
McEneaney V; Dooley R; Harvey BJ; Thomas W
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):18-28. PubMed ID: 19804826
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
Wang Q; Zhou Y; Wang X; Evers BM
Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.
Lønne GK; Masoumi KC; Lennartsson J; Larsson C
J Biol Chem; 2009 Nov; 284(48):33456-65. PubMed ID: 19833733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
